Clinical Trials Browser

Phase 1 × Recurrence × LY3214996 × Clear all

NCT04081259 2025-05-08

LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy

Phase 1 Completed

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute